Device type · DFC
Lipoprotein, Low-Density, Antigen, Antiserum, Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DFC
Immunology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
8
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Lipoprotein, Low-Density, Antigen, Antiserum, Control
- Product code
- DFC
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5600
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DFC
Latest FDA decisions
K253069 · Decided Jun 16, 2026 · 266 days after receipt
Device type: Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC) · Laboratory Medicine & Pathology
K241220 · Decided Jan 24, 2025 · 268 days after receipt
Device type: Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC) · Laboratory Medicine & Pathology
- Lp(a) Ultra510(k)
K211058 · Decided Dec 22, 2022 · 622 days after receipt
Device type: Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Reports received
8
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
8
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 2 | 0 | 0 | 0 |
| May 24 | 2 | 0 | 0 | 0 |
| Jun 24 | 2 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 4 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 4 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results4
- Non Reproducible Results4
- Low Test Results2
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions8
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403Open, Classified
Z-1017-2025 · Started Dec 20, 2024 · Posted by FDA Jan 23, 2025
Reason given: Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.
Cause as FDA categorized it: No Marketing Application
- Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757Open, Classified
Z-1018-2025 · Started Dec 20, 2024 · Posted by FDA Jan 23, 2025
Reason given: Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.
Cause as FDA categorized it: No Marketing Application
Z-1994-2019 · Started May 16, 2018
Reason given: An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products.
Cause as FDA categorized it: Under Investigation by firm
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.